Bessemer Group Inc. Acquires 15,033 Shares of HealthEquity, Inc. $HQY

Bessemer Group Inc. grew its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 4.0% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 388,422 shares of the company’s stock after buying an additional 15,033 shares during the quarter. Bessemer Group Inc.’s holdings in HealthEquity were worth $32,460,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in HQY. Wasatch Advisors LP lifted its position in HealthEquity by 9.3% during the 1st quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock worth $601,949,000 after buying an additional 613,288 shares in the last quarter. Geode Capital Management LLC increased its position in HealthEquity by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after acquiring an additional 5,671 shares in the last quarter. Westfield Capital Management Co. LP raised its stake in shares of HealthEquity by 13.7% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after acquiring an additional 235,794 shares during the last quarter. William Blair Investment Management LLC bought a new position in shares of HealthEquity in the fourth quarter worth about $169,956,000. Finally, AQR Capital Management LLC lifted its position in shares of HealthEquity by 59.3% during the third quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock worth $167,200,000 after purchasing an additional 656,820 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. This trade represents a 7.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on HQY shares. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and increased their price target for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, July 4th. Barrington Research reiterated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research note on Monday, June 1st. Finally, Citizens Jmp upped their price target on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday, June 1st. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Trading Down 1.0%

HQY opened at $97.67 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The company has a market cap of $8.17 billion, a price-to-earnings ratio of 36.58, a price-to-earnings-growth ratio of 1.64 and a beta of 0.21. The firm has a 50 day simple moving average of $88.76 and a 200 day simple moving average of $84.78. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. The firm’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, sell-side analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.